Biogen, Inc.

About Biogen, Inc.

Biogen is an American biotechnology company that develops and manufactures therapies for neurological and neurodegenerative diseases. Founded in 1978, the company focuses on treatments for conditions such as multiple sclerosis, Alzheimer’s disease, spinal muscular atrophy, and amyotrophic lateral sclerosis (ALS). It also produces biosimilar drugs for immune and inflammatory diseases. Biogen operates globally with research, development, and manufacturing facilities supporting its mission to improve outcomes for patients with serious neurological disorders.